Lung regeneration using amniotic fluid mesenchymal stem cells.

Azargoon, A and Negahdari, B (2018) Lung regeneration using amniotic fluid mesenchymal stem cells. Artif Cells Nanomed Biotechnol, 46. pp. 447-451.

Full text not available from this repository.
Official URL: https://www.ncbi.nlm.nih.gov/pubmed/28675062

Abstract

Abstract Respiratory diseases, such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension and lung fibrosis, are yet a major challenge in the world and they result in irreversible structural lung damage. Lung transplantation as the only therapeutic option face some major challenges like graft rejection and cancer, arising as a result of immunosuppression. A low survival rate faced by lung transplantation patients is presently limited to approximately 5 years. Lungs shortage therefore calls for a mechanism that would increase the availability of suitable organs for transplantation. In this review, we give an update on the use of amniotic fluid mesenchymal stem cells (AFMSCs) as an optimal source for lungs scaffold re-cellularization, due to their limitless accessibility and possibility for proliferation and differentiation. Further studies will be required in tissue engineering (TE) and regenerative medicine (RM), especially shifting our focus towards AFMSCs as a cell source for this regeneration. KEYWORDS: Re-cellularization; amniotic fluid mesenchymal stem cells; lung; regeneration

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: sobhan rezaiian
Date Deposited: 12 Apr 2018 10:53
Last Modified: 12 Apr 2018 10:53
URI: http://eprints.lums.ac.ir/id/eprint/1230

Actions (login required)

View Item View Item